AbbVie (ABBV) Shares Outstanding (2013 - 2026)

AbbVie (ABBV) has 14 years of Shares Outstanding data on file, last reported at $1.8 billion in Q1 2026.

• Shares Outstanding for Q1 2026 came in at $1.8 billion, changed 0.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 billion (changed 0.06% YoY), and the FY2025 annual result was $1.8 billion, changed 0.17% from the prior year.
• Shares Outstanding steadied at $1.8 billion in Q1 2026 per ABBV's latest filing, from $1.8 billion in the prior quarter.
• Over five years, Shares Outstanding peaked at $1.8 billion in Q3 2025 and troughed at $1.8 billion in Q1 2023.
• A 5-year average of $1.8 billion and a median of $1.8 billion in 2023 frame the typical range for Shares Outstanding.
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding declined 0.17% in 2023, then climbed 0.17% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $1.8 billion in 2022, then dropped by 0.17% to $1.8 billion in 2023, then retreated by 0.06% to $1.8 billion in 2024, then rose by 0.17% to $1.8 billion in 2025, then dropped by 0.06% to $1.8 billion in 2026.
• Business Quant data shows ABBV's Shares Outstanding at $1.8 billion in Q1 2026, $1.8 billion in Q4 2025, and $1.8 billion in Q3 2025.